- Hem
- Böcker
- Kurslitteratur
- Ekonomi
- From Breakthrough to Blockbuster (inbunden, eng)
From Breakthrough to Blockbuster (inbunden, eng)
Financial Times Business Top Title March 2022How could a large collection of small companies, most with fewer than 50 employees, rise to com...
519 kr
I lager
Skickas inom 2-3 vardagar
- Fri frakt
Fri frakt över 299:-
Snabb leverans
Alltid låga priser
Produktbeskrivning
Financial Times Business Top Title March 2022How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world''s most breathtakingly expensive and highly regulated industries?Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines.
As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources.
Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster: The Business of Biotechnology focuses on both the companies themselves and the broader biotech ecosystem that supports them.
It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency.
In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.
As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources.
Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster: The Business of Biotechnology focuses on both the companies themselves and the broader biotech ecosystem that supports them.
It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency.
In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.
Format | Inbunden |
Omfång | 240 sidor |
Språk | Engelska |
Förlag | Oxford University Press Inc |
Utgivningsdatum | 2022-07-07 |
ISBN | 9780195084009 |
Specifikation
Böcker
- Inbunden, 240, Engelska, Oxford University Press Inc, 2022-07-07, 9780195084009
Leverans
Vi erbjuder flera smidiga leveransalternativ beroende på ditt postnummer, såsom Budbee Box, Early Bird, Instabox och DB Schenker. Vid köp över 299 kr är leveransen kostnadsfri, annars tillkommer en fraktavgift från 29 kr. Välj det alternativ som passar dig bäst för en bekväm leverans.
Betalning
Du kan betala tryggt och enkelt via Avarda med flera alternativ: Swish för snabb betalning, kortbetalning med VISA eller MasterCard, faktura med 30 dagars betalningstid, eller konto för flexibel delbetalning.
Specifikation
Böcker
- Format Inbunden
- Antal sidor 240
- Språk Engelska
- Förlag Oxford University Press Inc
- Utgivningsdatum 2022-07-07
- ISBN 9780195084009